RUNX1 targeting AKT3 promotes alveolar hypercoagulation and fibrinolytic inhibition in LPS induced ARDS.

"the chip-seq read data have been deposited in the gene expression omnibus database (geo) under accession number gse236748."

"Declarations Ethics approval and consent to participateAnimal ethics approval has been granted by Guizhou Medical University Hospital. Participants consent to publish is not applicable. Consent for publicationAll authors have read and approved the manuscript for publication. Competing interestsThe authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Competing interests The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

"Funding This study was supported by the National Natural Science Foundation of China [82360019], and by National Natural Science Foundation of China [82160365]."